announces

Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader platform February 03, 2026 13:08 ET  | Source:…

1 month ago

RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy

February 03, 2026 13:06 ET  | Source: Restem Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L…

1 month ago

Cango Inc. Announces January 2026 Bitcoin Production and Mining Operations Update

DALLAS, Feb. 3, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its…

1 month ago

GTIA Announces $5 Million Charitable Giving Commitment for 2026

Members Help Power a More Than 160% Increase Over 2025 GivingOAKBROOK TERRACE, Ill., Feb. 2, 2026 /PRNewswire/ -- The Global…

1 month ago

ZEISS announces NMPA approval in China for powerful ophthalmic microscopes enhancing surgical visualization

ZEISS ARTEVO 750 and ZEISS ARTEVO 850 surgical microscopes provide ophthalmic surgeons in China with end-to-end workflow integration to improve…

1 month ago

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 02, 2026 16:05 ET  | Source: Candel Therapeutics NEEDHAM, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc.…

1 month ago

Arctic Vision Announces Deal to Integrate MDCO Technologys Ophthalmic Device Business to Form a Global DrugDevice Innovation Platform

SHANGHAI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Headquartered in Shanghai, Arctic Vision (Cayman) Limited (“Arctic Vision”), a global ophthalmic company,…

1 month ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

DUBAI, United Arab Emirates, Jan. 31, 2026 (GLOBE NEWSWIRE) -- Building on the unprecedented success of its 2025 Masterclass, AEON…

1 month ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

January 30, 2026 17:15 ET  | Source: Enzon Pharmaceuticals, Inc CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals,…

1 month ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced…

1 month ago